title: Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
abstract: Antipsychotics are the mainstay of treatment for patients with schizophrenia. However, these medications only work if they are taken and perhaps work best if they are taken for longer periods of time than seen in typical research trials. Here we explore the idea of "time as drug" by reviewing the data showing the potential benefits of long-term antipsychotic use. We also discuss the utility of depot antipsychotic formulations for improving the chances of attaining long-term therapeutic results.
authors: Neuroscience Education Institute, Carlsbad, CA, USA. smstahl@neiglobal.com
authors: Debbi A
authors: DA
authors: Morrissette
authors: Stephen M
authors: SM
authors: Stahl
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001921:Brain / Q000187:drug effects / Q000473:pathology; D003692:Delayed-Action Preparations; D057915:Drug Substitution; D006801:Humans; D008134:Long-Term Care; D055118:Medication Adherence / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000523:psychology; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D012565:Schizophrenic Psychology; D016019:Survival Analysis; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations